ONDINE BIOMEDICAL INC.CDI (VF5) — Net Asset Quality Index
ONDINE BIOMEDICAL INC.CDI (VF5) has a Net Asset Quality Index of 53.6% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €12.82 Million minus total liabilities of €5.95 Million yields net assets of €6.88 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of ONDINE BIOMEDICAL INC.CDI for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
ONDINE BIOMEDICAL INC.CDI Net Asset Quality Index Over Time (2021–2024)
This chart shows how ONDINE BIOMEDICAL INC.CDI's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the index stands at 53.6%, representing net assets of €6.88 Million against total assets of €12.82 Million EUR. For live market cap and overall valuation, see ONDINE BIOMEDICAL INC.CDI market cap and net worth.
Annual Net Asset Quality Index for ONDINE BIOMEDICAL INC.CDI (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for ONDINE BIOMEDICAL INC.CDI from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See net assets of ONDINE BIOMEDICAL INC.CDI for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 53.6% | €6.88 Million | €12.82 Million | €5.95 Million | ▲ +17.3 pp |
| 2023 | 36.4% | €2.08 Million | €5.73 Million | €3.65 Million | ▼ -33.9 pp |
| 2022 | 70.3% | €11.64 Million | €16.57 Million | €4.92 Million | ▼ -16.6 pp |
| 2021 | 86.9% | €29.66 Million | €34.14 Million | €4.48 Million | — |